June 8, 2025

Clinicians can ‘chat’ with medical records through new AI software, ChatEHR

by Hanae Armitage, Stanford University edited by Lisa Lock, reviewed by Andrew Zinin   Credit: Pixabay/CC0 Public Domain In much the same way people can “chat” with large language models like GPT-4, Stanford Health Care clinicians can now interact with a patient’s medical records through an AI-backed software called ChatEHR. The technology, currently in a pilot stage, enables […]

Clinicians can ‘chat’ with medical records through new AI software, ChatEHR Read More »

AI-powered tool set to transform type 1 diabetes diagnosis and treatment

by Ali Sardyga, Western Sydney University edited by Lisa Lock, reviewed by Robert Egan   Details of the study samples, their T1D status across the four contexts and the number of samples randomized for a training dataset (to generate the DRS4C model) and a testing dataset (to assess the performance of this model). Credit: Nature Medicine (2025). DOI: 10.1038/s41591-025-03730-7 Western

AI-powered tool set to transform type 1 diabetes diagnosis and treatment Read More »

Novel PDE10A Inhibitor for Acute Schizophrenia Safe, Effective in Large Phase 2 Trial

LOS ANGELES — The novel phosphodiesterase 10A (PDE10A) inhibitor known as CPL’36 (Celon Pharma) is effective and generally safe in acute exacerbations of schizophrenia, new research suggested. In a phase 2 trial of 189 patients with acute schizophrenia, compared with the placebo group, the groups receiving CPL’36 20 or 40 mg once daily both met

Novel PDE10A Inhibitor for Acute Schizophrenia Safe, Effective in Large Phase 2 Trial Read More »

Tumor diagnostics: AI model detects more than 170 types of cancer

by Charité – Universitätsmedizin Berlin edited by Gaby Clark, reviewed by Robert Egan   The AI model, crossNN compares the epigenetic data of unknown tumors to the fingerprints of over 8,000 reference tumors. A cross marks the tumor to be examined. The visualization shows the large amount of data on which the model is based. Each dot

Tumor diagnostics: AI model detects more than 170 types of cancer Read More »

Probiotics: What You Need to Know for Better Patient Care

What Are Probiotics? Probiotics are live microorganisms, such as bacteria or yeasts from the gut or other microbiota that, when consumed in sufficient amounts, support health by targeting specific bodily functions. Health Benefits Probiotics support gut health by enhancing the immune defenses of the intestinal lining and directly competing with harmful bacteria to maintain a balanced microbiome.

Probiotics: What You Need to Know for Better Patient Care Read More »

The Extra-Bacterial Gut Ecosystem: The Influence of Phages and Fungi in the Microbiome

WASHINGTON, DC — Research on the gut microbiome — and clinical attention to it — has focused mainly on bacteria, but bacteriophages and fungi play critical roles as well, with significant influences on health and disease, experts said at the Gut Microbiota for Health (GMFH) World Summit 2025. Fungi account for < 1% of the total

The Extra-Bacterial Gut Ecosystem: The Influence of Phages and Fungi in the Microbiome Read More »

Diet Drinks, Saccharin Tied to Increased Diabetes Risk

ORLANDO, Fla. — Consuming higher amounts of diet drinks and/or saccharin was associated with an elevated risk of developing diabetes, while total artificial sweetener intake, sucralose, and aspartame showed no significant association, according to an analysis of data from the Coronary Artery Risk Development in Young Adults (CARDIA) study. 30-Year Study The current analysis, presented at

Diet Drinks, Saccharin Tied to Increased Diabetes Risk Read More »

Chemists design a next generation of weight-loss drugs

by Mike Silver, Tufts University edited by Lisa Lock, reviewed by Robert Egan   Credit: Journal of the American Chemical Society (2025). DOI: 10.1021/jacs.5c04095 Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population. Despite their effectiveness, they have drawbacks. Their effect may not last after discontinuing use,

Chemists design a next generation of weight-loss drugs Read More »

Fecal transplants: Promising treatment or potential health risk?

by University of Chicago edited by Sadie Harley, reviewed by Robert Egan   Credit: Pixabay/CC0 Public Domain Fecal microbiota transplants (FMT) have been touted as a potential treatment for a variety of conditions, from inflammatory bowel diseases, obesity, and type 2 diabetes to autism. New research from the University of Chicago, however, cautions against widespread use of FMT

Fecal transplants: Promising treatment or potential health risk? Read More »

Implementing ECG-AI in Clinical Care

From Pixel to Practice Minjae Yoon, MD; Seng Chan You, MD, PHD DisclosuresJ Am Coll Cardiol. 2025;85(12):1314 –1316 There is no doubt that artificial intelligence (AI) is transforming cardiology practice.[1] Recently, many studies have focused on AI applications in electrocardiogram (ECG) analysis. These ECG-AI models not only excel at identifying obvious findings such as rhythm disorders and

Implementing ECG-AI in Clinical Care Read More »

Scroll to Top